ATE319709T1 - Indolderivate zur behandlung von depression und angstzuständen - Google Patents

Indolderivate zur behandlung von depression und angstzuständen

Info

Publication number
ATE319709T1
ATE319709T1 AT00982252T AT00982252T ATE319709T1 AT E319709 T1 ATE319709 T1 AT E319709T1 AT 00982252 T AT00982252 T AT 00982252T AT 00982252 T AT00982252 T AT 00982252T AT E319709 T1 ATE319709 T1 AT E319709T1
Authority
AT
Austria
Prior art keywords
anxiety
depression
treatment
indole derivatives
withdrawal
Prior art date
Application number
AT00982252T
Other languages
English (en)
Inventor
Marvin Martin Hansen
John Xiaoqiang He
Nicholas Allan Honigschmidt
Daniel James Koch
Todd Jonathan Kohn
Vincent Patrick Rocco
Patrick Gianpietro Spinazze
Kumiko Takeuchi
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE319709T1 publication Critical patent/ATE319709T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AT00982252T 1999-12-20 2000-12-06 Indolderivate zur behandlung von depression und angstzuständen ATE319709T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17274899P 1999-12-20 1999-12-20

Publications (1)

Publication Number Publication Date
ATE319709T1 true ATE319709T1 (de) 2006-03-15

Family

ID=22629052

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00982252T ATE319709T1 (de) 1999-12-20 2000-12-06 Indolderivate zur behandlung von depression und angstzuständen

Country Status (7)

Country Link
US (1) US7144898B2 (de)
EP (1) EP1242411B1 (de)
AT (1) ATE319709T1 (de)
AU (1) AU1930801A (de)
DE (1) DE60026581T2 (de)
ES (1) ES2259619T3 (de)
WO (1) WO2001046181A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL165863A0 (en) 2002-06-24 2006-01-15 Schering Corp Indole derivatives useful as histamine H3 antagonists
AR070398A1 (es) * 2008-02-22 2010-03-31 Gruenenthal Chemie Derivados sustituidos de indol
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
US11116357B2 (en) 2013-03-15 2021-09-14 Taylor Commercial Foodservice, Llc Cooking gap control of a cooking apparatus
CN108129251A (zh) * 2017-12-22 2018-06-08 上海应用技术大学 一种2-乙基苯乙烯的合成工艺
CN108314630B (zh) * 2018-02-08 2020-11-06 广西民族大学 一种肟醚类衍生物及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2337461A1 (de) * 1973-07-24 1975-02-06 Boehringer Mannheim Gmbh Neue indolderivate und verfahren zu deren herstellung
WO1980000152A1 (fr) * 1978-07-03 1980-02-07 Sandoz Ag Derives d'un 3-aminopropoxy-aryle, leur preparation et utilisation
EP0025111B1 (de) * 1979-08-10 1984-07-25 Sandoz Ag 3-Aminopropoxyaryl-Derivate, ihre Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
US5300498A (en) * 1993-06-04 1994-04-05 Hoechst-Roussel Pharmaceuticals Incorporated 6-piperazinyl-1H-pyrazolo[3,4-b]pyridine-3-carboxylic acids, esters, amides and related compounds
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5789402A (en) * 1995-01-17 1998-08-04 Eli Lilly Company Compounds having effects on serotonin-related systems
US5627196A (en) * 1995-01-17 1997-05-06 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5912256A (en) * 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems
AU4977899A (en) 1998-07-27 2000-02-21 Eli Lilly And Company Treatment of anxiety disorders
US6242450B1 (en) 1998-07-27 2001-06-05 Eli Lilly And Company 5-HT1F antagonists
ES2244438T3 (es) 1999-05-24 2005-12-16 Mitsubishi Pharma Corporation Compuestos de fenoxipropilamina.

Also Published As

Publication number Publication date
US20040006229A1 (en) 2004-01-08
DE60026581T2 (de) 2006-12-28
AU1930801A (en) 2001-07-03
EP1242411A1 (de) 2002-09-25
ES2259619T3 (es) 2006-10-16
US7144898B2 (en) 2006-12-05
EP1242411B1 (de) 2006-03-08
DE60026581D1 (de) 2006-05-04
WO2001046181A1 (en) 2001-06-28

Similar Documents

Publication Publication Date Title
DE60122767D1 (de) Indoly-lsulphonyl-verbindungen zur behandlung von störungen des zns
MY144483A (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
DE60208221D1 (de) Heterozyklische verbindungen zur behandlung von harnwegserkrankungen
CY1107747T1 (el) Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης
ATE357438T1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
DE60140871D1 (de) Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase
ATE260653T1 (de) Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen
DE60014136D1 (de) Sapogenin derivate zur behandlung von kognitiven störungen
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
ATE367380T1 (de) Zur behandlung von zns-erkrankungen geeignete piperazinylchinolinderivate
DE60220385D1 (de) Benzimidazole zur behandlung sexueller fehlfunktionen
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
ATE255094T1 (de) Piperazinderivate zur behandlung der niedrigen harnwege
DE60026581D1 (de) Indolderivate zur behandlung von depression und angstzuständen
AU2251801A (en) Piperidine derivatives and their use as serotonin receptor antagonists
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
ATE346040T1 (de) Aryl-sulfonamide als serotonin-antagonisten für de behandlung von fettleibigkeit
DE60213365D1 (de) Verwendung von mglur5 antagonisten zur behandlung von pruritischen zuständen
DE60010934D1 (de) Medikamente geeignet zur Behandlung von proliferativen Erkrankungen
DE60130691D1 (de) Indolderivate zur Behandlung von Erkrankungen des Zentralnervensystems
YU22802A (sh) Izonipekotamidi za lečenje poremećaja nastalih posredstvom integrina
DE60009315D1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
JO2724B1 (en) 3-Alternative-5 -6-Amino Alkyl Indole-2-Carboxyl Acid Amide and Related Isotopes as Casein Kinase Inhibitors
ATE519740T1 (de) Tetrahydroindolderivate zur behandlung von alzheimer-krankheit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties